We are live on ! Find out more
SGA

Sector Gamma AS Portfolio holdings

AUM $423M
1-Year Est. Return 17.56%
This Fund
S&P 500
This Quarter Est. Return
-3.32%
1 Year Est. Return
+17.56%
3 Year Est. Return
+28.73%
5 Year Est. Return
+52.48%
10 Year Est. Return
+238.19%
AUM
$306M
AUM Growth
-$6.25M
Cap. Flow
+$6.8M
Cap. Flow %
2.22%
Top 10 Hldgs %
51.08%
Holding
39
New
6
Increased
12
Reduced
17
Closed
1

Top Buys

Rank Stock Value
1
MRK icon
Merck
MRK
+$16.1M
2
TMO icon
Thermo Fisher Scientific
TMO
+$10.7M
3
AVTR icon
Avantor
AVTR
+$5.1M
4
LH icon
Labcorp
LH
+$4.74M
5
BIIB icon
Biogen
BIIB
+$3.99M

Top Sells

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$16.3M
2
EW icon
Edwards Lifesciences
EW
+$6.04M
3
THC icon
Tenet Healthcare
THC
+$4.59M
4
AMGN icon
Amgen
AMGN
+$4.25M
5
ELV icon
Elevance Health
ELV
+$4.02M

Sector Composition

Rank Sector Weight
1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DXCM icon
26
DexCom
DXCM
$29.2B
$4.36M 1.43%
+50,000
New +$3.92M
BIO icon
27
Bio-Rad Laboratories Class A
BIO
$8.08B
$4.3M 1.41%
17,829
+4,000
+29% +$946K
ELAN icon
28
Elanco Animal Health
ELAN
$12.6B
$4.17M 1.36%
292,073
-185,000
-39% -$2.16M
LNTH icon
29
Lantheus
LNTH
$6.8B
$4.12M 1.35%
50,301
+25,301
+101% +$2.22M
BNTX icon
30
BioNTech
BNTX
$23.3B
$3.99M 1.3%
37,470
+7,470
+25% +$754K
TNDM icon
31
Tandem Diabetes Care
TNDM
$1.24B
$3.92M 1.28%
210,523
+30,000
+17% +$594K
EW icon
32
Edwards Lifesciences
EW
$48.9B
$3.28M 1.07%
42,000
-81,000
-66% -$6.04M
HCA icon
33
HCA Healthcare
HCA
$82.2B
$3.06M 1%
+8,000
New +$2.88M
TGTX icon
34
TG Therapeutics
TGTX
$8.26B
$2.95M 0.96%
82,000
+27,000
+49% +$1.01M
ASND icon
35
Ascendis Pharma A/S
ASND
$16.5B
$2.93M 0.96%
17,000
– –
SOLV icon
36
Solventum
SOLV
$13.7B
$2.88M 0.94%
38,000
+8,000
+27% +$566K
THC icon
37
Tenet Healthcare
THC
$16.7B
$2.2M 0.72%
12,500
-30,500
-71% -$4.59M
ACLX
38
DELISTED
Arcellx
ACLX
$1.65M 0.54%
25,000
-10,000
-29% -$623K
JNJ icon
39
Johnson & Johnson
JNJ
$599B
– –
-98,000
Closed -$16.3M
1
2

Similar funds

AFWM
AMJ Financial Wealth Management Leesburg, Virginia $424M AUM 37.24% 1-Year Est. Return
MP
McDonald Partners Cleveland, Ohio $424M AUM 29.07% 1-Year Est. Return
DS
Dalal Street West Lake Hills, Texas $423M AUM 115.19% 1-Year Est. Return
RS
Retirement Solution Redmond, Washington $423M AUM 16.83% 1-Year Est. Return
DF
Dunhill Financial London, United Kingdom $424M AUM 16.79% 1-Year Est. Return
OGM
OnyxPoint Global Management New York $424M AUM 84.95% 1-Year Est. Return
CPIM
Cypress Point Investment Management Mill Valley, California $424M AUM
MPPLM
Midwest Professional Planners Ltd (MPPL) Wausau, Wisconsin $425M AUM 28.89% 1-Year Est. Return

Sector Gamma AS's Q2 2025 Portfolio in Review

As of Q2 2025, Sector Gamma AS held 39 positions worth $306M, down 2% from $312M the previous quarter. Its ten largest holdings account for 51% of the portfolio.

Sector Gamma AS's Q2 2025 filing shows 6 new, 12 increased, 17 reduced and 1 closed positions. Its largest new stake was Merck: 202,000 shares worth $16M. The largest sale was Johnson & Johnson, an estimated $16.3M.

By sector, the portfolio is most concentrated in Healthcare at 100% of assets, unchanged from a quarter earlier.

  • Sector Gamma AS's largest Q2 2025 buy was Merck: 202,000 shares worth $16M.
  • Sector Gamma AS added most to Biogen in Q2 2025, an estimated $3.99M increase.
  • Sector Gamma AS's biggest Q2 2025 reduction was Edwards Lifesciences, cutting an estimated $6.04M.
  • Sector Gamma AS fully exited Johnson & Johnson in Q2 2025, selling an estimated $16.3M.
  • Sector Gamma AS's ten largest holdings make up 51% of its $306M portfolio in Q2 2025.
  • Sector Gamma AS opened 6 new positions and closed 1 in Q2 2025.
  • Sector Gamma AS's portfolio value fell 2% quarter-over-quarter to $306M.

Based on Sector Gamma AS's 13F filing for Q2 2025, filed 31 Jul 2025.